Healthcare Industry Insights: 2022

Friday 30 December 2022

Medical Lifting Sling Market: Future Demand, Market Analysis & Outlook to 2030

The global Medical Lifting Sling Market is anticipated to reach USD 1.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.5% from 2022 to 2030. Expanding geriatric and disabled population coupled with rising need for home healthcare products are propelling the market growth. Geriatric population forms the target population for this market. This demographic is highly susceptible to age-related disorders that in certain cases causes immobility. Moreover, the advent of long-term care centers and elderly care centers is creating growth opportunities for market players.

The outbreak of COVID-19 in the year 2020 has positively impacted the medical lifting sling market growth. Increased number of COVID-19 cases and high demand for ventilator support, surged the importance of having supporting aids during the entire stay in hospital. In addition, WHO published the guidance for using disposable medical lifting slings and other equipment, regarding the management of COVID-19 patients. These factors are anticipated to create huge growth opportunities for market players over the forecast period.

Moreover, the prevalence of disabilities is also boosting the demand for the slings. As per the data published by WHO, around 15% of the world’s population lives with some form of disability. Out of those some 2% to 4% population experience difficulties in functioning. Old people of 80 years or above are about eight times more likely to have a disability. As per the data published by the U.S. Census Bureau, around 19.9 million people had difficulty in lifting and grasping. All these factors are positively influencing the need for assistive devices like medical lifting slings to obtain mobility.

Related Press Release @ Medical Lifting Sling Market Report

Medical Lifting Sling Market Report Highlights

Based on product, nylon slings accounted for the largest market share of 29.30% in 2021 owing to the associated benefits, which include greater durability, reusability, and their availability in multiple shapes and sizes.
Based on application, transfer slings was the largest segment in 2021 in terms of revenue and is anticipated to remain the same over the forecast period. Reason being its purpose which includes transferring a patient to and or from a chair, bed and from floor.
Hospitals formed the largest end-user for these products in 2021. The huge patient pool and a greater financing capability facilitate bulk purchasing of these products in hospitals.
Europe medical lifting sling market dominated with around 32.59% market share in 2021 to the higher research expenditure, more initiatives to provide advanced devices, and private-public partnerships.
Asia Pacific is expected to grow at a rapid pace over the forecast owing to the increasing per capita income and the presence of high unmet needs of the huge population pool in this region.

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Thursday 29 December 2022

Mammography Market Hologic Inc.; Analogic Corp.; Canon Medical Systems Corp.; Fujifilm Corp.

The global Mammography Market size is expected to reach USD 4.67 billion by 2030, registering a CAGR of 10.26% according to a new report by Grand View Research, Inc. The growth is mainly driven by the rising initiatives by various governments and NGOs to raise awareness about the early diagnosis of microcalcifications in breast tissue.

For instance, the National Breast Cancer Screening Programme in the Netherlands, for example, was created for women aged 50 to 75. According to the program, women in this age bracket were invited for a mammogram every two years. Similarly, in Australia, women aged 50 to 74 are required to have free mammograms every 2 years as part of the government's national screening program, Breast Screen Australia. Some other significant organizations such as the National Breast Cancer Foundation, CDC, and Breast Cancer Organization are promoting early diagnosis of mammary gland calcification. This is one of the crucial factors expected to drive market growth.

Major mammography manufacturers are introducing new products and increasing the number of approved products, which is further expected to impel the demand in the coming years. For instance, in March 2018, Siemens Healthineers obtained U.S. FDA approval for its enhanced mammography platform MAMMOMAT Revelation. This platform is combined with a new InSpect specimen imaging tool as well as new HD Breast Biopsy technology for one-click targeting of affected areas. Moreover, in October 2021, iCAD, Inc. launched its latest generation of ProFound AI for 2D Mammography.

Furthermore, the use of Artificial Intelligence (AI) in 3D mammography has reduced exam time while maintaining image quality. For instance, in March 2021, iCad received USFDA approval for its ProFound AI Version 3.0 for Digital Breast Tomosynthesis (DBT) system. Compared to previous versions of the software, it provides up to a 10% enhancement in specificity performance, up to 1% improvement in sensitivity, and offers 40% faster processing. Thus, rapid FDA approval for AI-enabled 3D mammography equipment is driving market growth.

Related Press Release@ Mammography Market Report

Mammography Market Report Highlights

Digital systems dominated the product segment in 2021 owing to the wide availability of digital breast screening devices and the presence of favorable reimbursements for such devices
Digital mammography dominated the technology segment in 2021 due to growing awareness regarding digital technology and increasing adoption of such technology for better diagnosis
In 2021, North America dominated due to the increasing adoption of technologically advanced screening devices and the upsurging number of approvals of 3D systems
Asia Pacific and Latin America are the two fastest-growing regional segments, because of the higher mammary gland cancer prevalence and the growing number of government campaigns to improve breast screening

Women’s Health And Beauty Supplements Market Size is Expected to Experience a CAGR of 4.8% till 2030

The global Women’s Health And Beauty Supplements Market size is expected to reach USD 84.4 billion by 2030, registering a CAGR of 4.8% during the forecast period, according to a new report by Grand View Research, Inc. Rising health consciousness among women and increasing consumer interest in active living coupled with the rising disposable income are among the key factors driving the market growth. In addition, rising awareness about the benefits of dietary supplements, increasing availability & access to these products, and an increasing number of distribution channels are further supporting the market growth. The vitamin product type segment dominated the market in 2021 due to the high demand for vitamin supplements.

Also, the growing demand for other vitamins, such as vitamins A, B, C, and E by women of all age groups suffering from vitamin deficiencies is driving the segment. Furthermore, companies across the globe are investing in the R&D of new vitamin products to meet the growing demand. In 2021, the women’s health application segment accounted for the highest revenue share owing to the increasing demand for women’s health supplements due to changing health trends and increasing awareness among women about health and nutrition. Also, the increasing prevalence of micronutrient deficiency; the rise in the need for dietary supplements in women, mainly in prenatal, premenstrual, & perimenopause stages are driving the segment growth. In 2021, the 31-50 years age group segment held the largest market share owing to the presence of a large consumer pool belonging to this age group.

Women of childbearing age, i.e., women aged 31 to 50 are the largest consumers of multivitamin or mineral supplements. Moreover, the risk of developing chronic diseases is high among this age group, which increases the dependency on preventive alternatives, thereby impelling the segment growth. In 2021, the others and postmenopause consumer group segments collectively accounted for the largest share of the market due to the availability of women’s health supplements with fewer adverse effects for general health conditions during postmenopause. In 2021, the direct sales channel segment held the largest market share owing to the high number of retail stores, which offer various discounts on products and flexible schemes to buyers, thereby attracting an increased number of customers.

Asia Pacific dominated the global market in 2021 owing to the growing consumer awareness about health & fitness and the availability of low-cost raw materials & a large number of domestic players in the region. In addition, the COVID-19 pandemic outbreak significantly increased the focus on health & wellness globally. This public health emergency created numerous growth opportunities, as people started consuming vitamins, minerals, and herbal supplements as a preventative measure against infection. Thus, a rise in the consumption of supplements to strengthen the immune system has been one of the key factors boosting product sales. Furthermore, there has been an increase in the demand for herbal supplements, such as elderberry and Echinacea. Moreover, the rise in levels of anxiety and stress owing to uncertainty due to the pandemic has increased consumer focus on self-care. This created the demand for wellness boosters & anxiety or stress management supplements and sleep aids, thereby supporting the market growth.

Related Press Release@ Women’s Health And Beauty Supplements Market Report

Women’s Health And Beauty Supplements Market Report Highlights

Increasing awareness about health and growing preference for preventative healthcare among women coupled with the availability of multiple products are the major factor driving the market growth
The emergence of e-commerce has raised the accessibility to dietary and beauty supplements. The online platforms are also flourishing in developing countries, which is positively impacting the market growth
The rising cases of women suffering from micronutrient deficiencies have augmented the demand for various nutritional supplements, thereby impelling the market growth
The increasing risk of product counterfeiting and various brand holders losing billions due to counterfeit products might hamper the market growth
The continuous change in regulatory policies and lack of a uniform regulatory framework are among the major challenges faced by market players

North America And Europe eHealth Market – Industry Insights By Product, 2030

The North America And Europe Ehealth Market size is expected to reach USD 403.15 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.5% from 2022 to 2030. The market is primarily driven by an increasing number of government initiatives to develop and deploy eHealth solutions, rising demand for centralization and streamlining of healthcare administration, and the advent of technologically advanced eHealth services. Furthermore, Electronic Health Record (EHR) systems benefit in tracking adverse drug events as well as aid in epidemiology studies, which is further expected to drive the market.

To combat the COVID-19 pandemic, numerous initiatives are being started by government and community organizations to support the present healthcare system. It includes front-line clinics by state management, a volunteer panel of doctors, and numerous remote telemedicine applications. eHealth plays a dynamic role during the pandemic as it is helping doctors make effective choices at the point of care. Thus, market players are exploiting this opportunity to address the problem and offer support to forefront doctors.

North America emerged as the largest market in 2021 due to the presence of a technologically advanced population base and various ongoing activities in the region. The aforementioned factors are expected to boost market expansion. The availability of high-tech healthcare infrastructure as well as high-speed internet can be attributed to the region's rapid expansion. As a result, improved awareness is projected to have a major impact on market growth.

According to a report published in 2021, around 50 medical hubs in the U.S. currently have such eHealth platforms and are using telemedicine to visit outpatients at home. These telemedicine and eHealth technologies are crucial for COVID-19 global management. According to the U.S. FDA, at least 54% of healthcare consumers in the country use FDA-approved apps and other online tools for the treatment, management, and monitoring of medical disorders.

In a severe health scenario, decision support is crucial. Furthermore, these systems analyze patient medical records and present a list of viable options from which to choose the most appropriate. The market's growth prospects have been boosted by the easy compatibility and interoperability of systems across platforms. Over the projection period, academics and software developers are expected to collaborate to make medical knowledge available to users, resulting in significant income-generating.

Furthermore, as a result of the COVID-19 pandemic, many new companies are entering the market, which is expected to enhance the market growth in the U.S. For instance, Cerner Corporation stated in 2020 that it will be offering its Community Works clients a new video care platform called the Video Visit program.

Related Press Release@ North America And Europe eHealth Market Report

North America And Europe eHealth Market Report Highlights

By product, health information systems (HIS) accounted for the largest revenue share of over 30.0% in 2021 owing to an increase in government initiatives and healthcare IT investments to develop and deploy IT systems in the healthcare industry. This is increasing the adoption of healthcare information systems
The monitoring services segment is poised to witness noteworthy growth over the coming years due to the rapid adoption of monitoring devices by clinicians and patients
Based on end-use, providers held the largest revenue share in 2021. Implementing home-based eHealth software is one method for providing more sustainable treatment for these patients
The telemedicine product segment is expected to witness lucrative growth over the forecast period owing to novel innovations for technical support and interoperability of telemedicine
Market players are involved in strategic initiatives such as new product launches, product innovations, acquisitions, and partnerships to gain a competitive edge over each other
For instance, in September 2021, Apple Inc. announced the launch of watchOS 8, which has overall health parameters configured. This had new features such as updated workout types, cycling monitors, and a mindfulness meditation app

Thursday 22 December 2022

In Vivo CRO Market Size is Estimated to Witness 8.5% CAGR till 2030

The global In Vivo Cro Market size is expected to reach USD 7.92 billion by 2030, registering a CAGR of 8.2% according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% during the forecast period. Increasing focus on core competencies by the pharmaceutical players coupled with economic efficiency offered for outsourcing is expected to boost the demand.

In Addition, the CROs are equipped with a competent workforce capable of performing a diverse number of tasks along with being well-versed through regulatory requirements. Also, the pressure from the increasing competition owing to the rapid growth of generics, patent expirations, and introduction of biosimilar equivalents are encouraging pharmaceutical companies to take the aid of such organizations.

Increasing mergers and collaborations have propelled the value of pharmaceutical outsourcing with major industry contributors expanding into developing regions. The year 2015 experienced high valued transactions as a result of LabCorp acquiring Covance for USD 5.5 billion and the Chinese Private Equity Group acquiring WuXifor for USD 3.3 billion.

Related Press Release@ In Vivo CRO Market Report

In Vivo CRO Market Report Highlights

Rodent-based In vivo CRO led the market in 2018 and is anticipated to remain dominant throughout the forecast period. Mice are the most used animal for preclinical evaluation and accounted for almost 76% of the market share in 2018.
Based on indication, oncology held the largest market share in 2018, attributed to the increasing number of cancer cases and the focus of pharmaceutical players on introducing novel drug treatments with fewer side-effects
North America led the global In vivo CRO market in 2018 owing to the presence of technologically advanced CROs
Asia Pacific is anticipated to register the fastest CAGR over the forecast period. Constantly improving healthcare infrastructure, huge patient base, presence of untapped opportunities, and economic development, are some factors responsible for the rapid growth
Some of the key market players include Pharmaceutical Product Development, LLC (PPD); IQVIA; American Preclinical Services, LLC.; Charles River Laboratories; Parexel International Corporation; ICON Plc; Covance Inc.; Theorem Clinical research; inVentiv Health; WuXi AppTec, Inc.; American Preclinical Services, LLC.; and Evotec (US), Inc. Partnership and mergers and acquisitions are the key strategic undertakings by these players

Tuesday 20 December 2022

Real-time PCR, Digital PCR, And End-point PCR Market – Industry Insights by Technology & Application

The global Real-Time PCR, Digital PCR, And End-Point PCR Market size are expected to reach USD 14.63 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to decline at a compound annual growth rate (CAGR) of 8.2% from 2022 to 2030. However, the real global real-time PCR, digital PCR, and end-point PCR market without the impact of the COVID-19 pandemic is expected to expand at a compound annual growth rate (CAGR) of 8.0% from 2022 to 2030. Digital PCR is a novel technique for absolute quantification and analysis of minority sequences in the presence of similar majority sequences. dPCR allows for precise and sensitive nucleic acid measurement. In addition, real-time PCR provides precise and early diagnosis of diseases and rapid and targeted patient care hence anticipated to increase the demand in the coming years.

The rise in the occurrence of diseases such as lung cancer, blood cancer, and brain tumors is fueling the application expansion of the global market. According to Globocan 2020, lung cancer is the second most common cancer in Europe, with an estimated 477,534 newly diagnosed cases. Furthermore, the benefits of digital polymerase chain reaction over traditional technologies such as real-time and quantitative polymerase chain reaction are likely to drive adoption throughout the forecast period. Moreover, rising healthcare expenditures in emerging nations and the increased need for accurate molecular disease detection are propelling the market growth.

Furthermore, the COVID-19 pandemic has increased the demand for digital PCR instruments and reagents. COVID-19 infections are detected using modern digital PCR instruments as a molecular diagnosis technique. According to the WHO, around 273 million cases have been diagnosed and roughly 5.3 million deaths have been documented worldwide due to COVID-19 as of December 2021. Moreover, in the pharmaceutical industry, digital PCR machines are also employed in R&D.

Furthermore, advancements in technology and an increase in the number of product launches in the global market are expected to support the market growth. For instance, in June 2021, Bio-Rad Laboratories, Inc. announced the release of the PREvalence ddPCR SARS-CoV-2 waste-water quantifying kit for COVID-19 wastewater screening.

Additionally, the increase in R&D projects for advancements in technology and an increase in collaborations between firms for the development of digital polymerase chain reactions are expected to increase the usage of PCR testing. For instance, Qiagen partnered with Atila BioSystems & Actome GmbH in January 2022 to deliver non-invasive prenatal testing (NIPT) technologies to QIAGEN's dPCR for a growing number of applications for QIAcuity. As a result, the usage of real-time and digital PCR technologies is projected to increase during the forecast period.

Related Press Release@ Real-time PCR, Digital PCR, And End-point PCR Market Report

Real-time PCR, Digital PCR, And End-point PCR Market Report Highlights

By technology, the quantitative segment held the largest revenue share in 2021. This is attributed to the high adoption of technology supported by the introduction of products based on real-time polymerase chain reaction for screening and diagnosis of COVID-19
The consumables and reagents product segment dominated the market in 2021 due to the increased demand for earlier detection and the number of significant companies manufacturing digital PCR consumables and reagents
North America dominated the global market in 2021 due to the presence of high R&D investment, the availability of a technologically advanced healthcare research framework, the strong presence of prominent polymerase chain reaction manufacturers, and an expanding requirement for rapid diagnostic tests in the region

Monday 19 December 2022

Intravenous Solutions Market Size Worth $22.01 Billion By 2030

The global Intravenous Solutions Market size is expected to reach USD 22.01 billion by 2030, registering a CAGR of 8.0% according to a new report by Grand View Research, Inc. The growing incidence rate of chronic diseases such as cancer, increase in the number of premature births, and shortage of I.V. solutions in the U.S. are some of the key factors expected to drive the market.

One of the prime areas wherein intravenous (IV) fluids find usage is severe dehydration. Severe dehydration is seen in diseases such as diarrhea, resulting in the depletion of fluids from the body. According to the WHO, in 2017, diarrhea was the second leading cause of death in children under 5 years of age with around 5,25,000 lives lost each year. Intravenous (IV) fluids can play a key role in the treatment and prevention of deaths caused due to dehydration/fluid loss associated with diarrhea. Other cases where intravenous fluids find application include surgeries and emergencies.

The ongoing COVID-19 pandemic is expected to have a positive impact on the market. Intensive Care Units (ICU) worldwide are either operating at full capacity or are overcrowded due to the high influx of patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As per an article published by BBC, in January 2021, critical care wards across England were running at full capacity. Nutritional care is one of the essential elements in managing these patients. This has increased the demand for intravenous (IV) fluids, as many of the patients, especially the elderly population are placed on ventilators and are unable to consume food orally.

Related Press Release@ Intravenous Solutions Market Report

Intravenous Solutions Market Report Highlights

The Total Parenteral Nutrition (TPN) segment led the segment in terms of revenue share in 2020 owing to its growing applications in the management of chronic diseases
The increasing number of surgeries and post-operative nutritional management is a prime factor driving the vitamins and minerals (salt and electrolyte) segment’s growth
North America dominated the market with a revenue share of nearly 40.8% in 2020 due to the high usage of IV fluids in the U.S.

Burn Care Centers Market Size Worth $31.9 Billion By 2030

The global Burn Care Centers Market size is expected to reach USD 31.9 billion by 2030, as per a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 4.1% from 2022 to 2030. The increasing global caseload is responsible for nearly 180,000 mortalities each year, as per the WHO. The majority of these incidences and accidents occur in lower-middle-income countries in the Asia Pacific and Latin American regions. The current market is witnessing an overall increase in the cost of care, which is a major driver behind the growth of the market.

According to an article published on UpToDate, burns rank 4^th in the common types of trauma, on a global level. It also states that low-middle income countries despite having high incidences of trauma, severely lack the necessary infrastructure and means to manage these patients. Another article published in Annals of Burns and Fire Disasters states that treatment and care in most of these countries are often delayed. Rural areas are more severely impacted due to the lack of proper medical facilities. For instance, in Ghana, only 48% of Pediatric injuries are treated at modern healthcare facilities.

In the facility type, the in-hospital type held the largest revenue share of more than 50.0% in 2021. The majority of developing and underdeveloped nations have a scarcity of specialized treatment units, due to which the patient load or volume goes to in-hospital settings. In these countries, the cost of care at specialized treatment units is much higher and is another reason why in-hospital settings record the majority of admissions. However, the stand-alone centers are forecasted to see a surge in growth rate. This can be credited to the growing need for the quality of care and management of patients that these units are capable of delivering.

In the treatment type, the largest revenue share was held by the wound-debridement section. It is the standard procedure in case of all injuries, this not only helps in avoiding infections but also promotes faster healing resulting in better outcomes. The highest growth potential has been exhibited by the pain management section for treatment type. Pain management in patients has come to be of paramount importance even when deciding the kind of wound dressing to be used for the patient. The pain during the healing process can have severe psychological implications due to which the recovery can be hampered, this is a primary driver for growth in this treatment type. A research article published in the Burns journal stated that the patient population studied considered several important factors while considering the type of dressing, nearly 80% responded with pain-free dressings as the most important characteristic.

The partial-thickness burns segment held the largest revenue share in 2021. The majority of the cases fall into the category of less than 10% TBSA. Partial-thickness wounds if not treated timely and properly can fester into infections and can turn fatal. The fastest growth is to be exhibited by the full-thickness burns and require management at specialized medical centers which are capable of providing advanced surgical and non-surgical interventions in care management. The in-patient services segment held the largest revenue share in 2021, owing to the increasing cost of treatment. There has been an overall decline in the annual number of cases, especially during COVID and otherwise as well. Workplaces have fire-safety norms in place to better manage situations to avoid accidents. The cost of care, however, has risen, and thus the market is growing. It is expected to grow lucratively during the forecast period.

North America accounted for the majority revenue share of over 40% in 2021. The region has the largest number of specialized burn care units, totaling to 120, across the U.S., many of which are verified by the American Burn Association. The reimbursement plans for patients also significantly support the growth of the North American market. The fastest growth however is being seen in the Asia Pacific region. This can be attributed to the improving healthcare infrastructure due to increased healthcare spending. As per World Bank data, East Asia and Pacific’s annual healthcare spending in 2019 was 6.7% of the region’s GDP, higher than the 2018 value.

The lack of proper resources has also been providing a necessary push to the concerned authorities to bring about the formation of specialized treatment units in the region’s countries. The above-listed reasons are contributing significantly to the growth of the market. There was an overall decline in the number of patients going to burn care units in hospitals or burn centers, the major focus was on the COVID-19 pandemic. However, due to global lockdowns and cross-border trade restrictions, the cost of materials and amenities shot up, ultimately increasing the overall cost of care being delivered to burn patients across the globe.

Related Press Release@ Burn Care Centers Market Report

Burn Care Centers Market Report Highlights

The market revenue is expected to reach USD 31.9 billion by 2030. The increasing need to find specialized care for burn patients is driving the market
The in-hospital segment bagged the largest revenue share owing to the limited number of specialized units
The pain management segment is anticipated to emerge as the fastest-growing treatment type for burn patients across the globe

Friday 16 December 2022

External Urine Management Products Market Worth $844.37 Million By 2030

The global External Urine Management Products Market size is anticipated to reach USD 844.37 million by 2030, registering a CAGR of 5.09% during the forecast period, according to a new report by Grand View Research, Inc. Increasing incidence of Urinary Incontinence (UI), along with the need for effective and long-term solutions for the management of UI is anticipated to boost the market growth. An increasing number of incontinent patients is expected to boost the demand for external urine management products, thereby boosting the market growth during the forecast period. For instance, according to Phoenix Physical Therapy, over 200 million people are affected with urinary incontinence worldwide. Women are more susceptible to UI as compared to men due to hormonal changes, pregnancy, or menopause.

Rising initiatives by several market players to raise awareness regarding incontinence care globally are successfully breaking the stigma and taboo associated with it. For instance, the World Federation of Incontinence Patients (WFIP) introduced an annual initiative called World Continence Week with the approval of the International Incontinence Society. This initiative has been started at the global level to spread awareness related to UI, bladder weakness, and other conditions. Moreover, the outbreak of the COVID-19 has spurred the demand for incontinence products, such as external urinary catheters used in home settings. Since most consumers are aged/seniors, there is a higher demand for these products. Restrictions on movement at international borders have created an opportunity for local players to enter the market and meet the unmet demands of the end-users.

Related Press Release@ External Urine Management Products Market Report

External Urine Management Products Market Report Highlights

Based on product, the male external catheters segment held the largest market share in 2021 challenges in the development of female external catheters are a major factor supporting the male external catheters segment growth
Moreover, around 10.00% of men aged 70 to 80 years are more likely to develop acute urinary retention
The offline segment held the largest share in 2021. The product sales through offline channels are rising due to more sustainability offered by these stores than any other channel
The hospitals segment held the largest market share in 2021 owing to the increase in hospital admission across the globe due to COVID-19
North America dominated the market in 2021 owing to the high prevalence of urological diseases, supportive government policies, and increasing awareness programs by celebrating World Incontinences Day every year

Positive Airway Pressure Devices Market Worth $3.6 Billion By 2030

The global Positive Airway Pressure Devices Market size is expected to reach USD 3.6 billion by 2030, registering a CAGR of 5.6% during the forecast period, according to a new report by Grand View Research, Inc. The healthcare industry is facing challenges owing to the rapidly growing prevalence of obstructive sleep apnea and sleep apnea-associated chronic comorbidities. Obstructive sleep apnea is a sleeping disorder, characterized by irregular breathing, thus providing insufficient oxygen to the brain. As per the global prevalence of obstructive sleep apnea estimates published in June 2022 by UpToDate, over 936 million individuals across the globe suffer from mild to severe sleep apnea.

Changing lifestyles owing to globalization and the adoption of unhealthy dietary habits are making individuals prone to obesity, Cardiovascular diseases (CVDs), diabetes, and hypertension, which are forerunners of obstructive sleep apnea. As per the estimates published by the World Population Review, 36.2% of the U.S. population is diagnosed as obese. In addition, the rapidly increasing geriatric population coupled with increasing life expectancy is anticipated to contribute to the incidence rate of obstructive sleep apnea and directly drive the demand for positive airway pressure devices (PAP) devices. The COVID-19 pandemic restrained the growth of the market owing to multiple lockdowns and travel restrictions imposed by governments across the globe to curb the transmission rate.

In addition, the postponement of elective procedures and infrastructural changes in healthcare facilities to accommodate COVID-19 care facilities negatively impacted the procedural volume, which hindered market growth. Healthcare facilities and sleep centers recorded a declining trend in diagnostic and therapeutic procedural volume, restricting the growth of PAP devices. The American Academy of Sleep Medicine (AASM) introduced protocols to adopt virtual consultations to address the declining sleep studies volume. However, during the initial months of the pandemic, PAP machines were being used as the first line of treatment and as an alternative to ventilators in mechanical ventilation. Global government bodies are devising strategies to promote awareness levels among the population and promote the adoption of PAP machines. The availability of favorable reimbursement policies is further boosting product adoption.

Related Press Release@ Positive Airway Pressure Devices Market Report

Positive Airway Pressure Devices Market Report Highlights

The CPAP devices segment dominated the market in 2021 owing to the growing incidence of obstructive sleep apnea and CPAP is the first line of treatment as it is more economical than other PAP devices
North America dominated the market in 2021 owing to the large patient pool, increasing disposable income levels, and presence of favorable insurance coverages
The prevalence of obstructive sleep apnea in the male population of North America is recorded to be 15-30% and in females, it is 10-15%
Key participants in the market are focusing on innovative product development strategies to expand their product portfolio and address the growing demand
Some of the latest features being incorporated in PAP machines are noise reduction and softer material to enhance patient comfort and compliance

Nurse Call Systems Market Size Worth $4.2 Billion By 2030

The global Nurse Call Systems Market size is expected to reach USD 4.2 billion by 2030, based on a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.96% from 2022 to 2030. The growth of the market can be attributed to the rising use of digital healthcare and the increasing need for patient safety and care. Furthermore, continuous technological advancements to bring new levels of communication enabling the widest range of applications configuration at home care, hospitals, or residential facilities are predicted to boost market demand.

The growing elderly population and rising risk of diseases such as chronic respiratory disease, hypertension, cardiovascular disease, and diabetes are increasing the demand for healthcare services. This patient population needs assistance to complete their day-to-day activities, thereby surging the demand for nurse call systems in some healthcare facilities. It ensures the safety of patients in the ward. Increasing demand for integrated and diversified hospital communication systems is anticipated to favor the market growth.

The COVID-19 pandemic has indiscriminately increased the pressure on healthcare facilities and professionals. As a result, the need for wireless communication devices increased in hospitals. Nurse call systems helped to decrease the burden on the existing staff force during the pandemic when hospitals were managing COVID-19 patients above their occupancy levels. Various manufacturers expanded their manufacturing capacity to meet the sudden surge in demand.

Related Press Release@ Nurse Call Systems Market Report

Nurse Call Systems Market Report Highlights

Based on technology, the wired communication equipment segment dominated the market in 2021. Wired systems have traditionally been used in several healthcare facilities to inform caregivers of a patient's needs
The high growth of the wireless communication equipment technology segment can be attributed to factors such as low cost of installation, easy integration with other devices, and ease of mobility. In January 2019, the Hill Rom launched its LINQ mobile application for improvement in communication between the patient and caregiver formerly in the U.S. and Canada with further expansion to Europe
In the type segment, integrated communication systems held the largest revenue share in 2021 owing to the advancement in communication devices, availability of data to be used by healthcare personnel, and rising demand for improved quality of care
On the basis of application, the wanderer control segment dominated the market in 2021 owing to the ease of communication, growing demand for digital technology, and rising aging population
North America dominated the market in 2021 owing to the adoption of the latest technology, the presence of established healthcare infrastructure, and advanced digital healthcare in the region

Thursday 15 December 2022

U.S. Behavioral Health Care Software And Services Market – Industry Insights by End-use

The U.S. Behavioral Health Care Software And Services Market size is expected to reach USD 3.0 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.12% from 2022 to 2030. An increase in the adoption of technological solutions for the management of clinical, administrative, and financial functions associated with mental healthcare practices is responsible for market growth.

According to the CDC data, around 20.3% of the adult American population was suffering from mental health issues in 2020. Out of which, around16.5% received treatment from the physicians and 10.1% took counseling. The adoption of behavioral healthcare software by the care providers is likely to improve the treatment prospects and management of mental health issues. Behavioral health practices can adopt integrated EHRs for cost savings and effective practice management. The adoption of mental well-being apps can aid to break the societal stigma on mental health. The stigma could easily lead to discrimination, which discourages people from seeking treatment or therapy. However, the surge in mental wellbeing software has led to more patients seeking treatment discreetly.

The COVID-19 pandemic has increased the demand for software by providers of behavioral health. For instance, according to the ECHAlliance Data 2020, around 600 prescription mental wellness apps are available in the market. In addition, the demand for such prescription apps surged drastically from April 2020 to September 2020. The adoption of telehealth and telemedicine also helped to foster the growth of the market during the pandemic. The utilization of mobile and virtual care platforms was supported by positive changes in reimbursement policies for telehealth. For instance, the CMS issued temporary changes in receiving care through telehealth services for patients enrolled in Children's Health Insurance Program (CHIP), Medicaid, and Medicare.

U.S. Behavioral Health Care Software And Services Market Report Highlights

By component, the integrated segment dominated the market in 2021. The segment is expected to register the fastest growth rate over the forecast period as it provides various functionalities such as telehealth, e-prescription, and billing and claims management in one single package
In terms of the delivery model, the subscription segment accounted for the largest revenue share in 2021. The segment is expected to register the fastest growth rate over the forecast period due to the increasing preference for subscription services over purchasing
Based on function, the clinical segment held the largest market share in 2021. The behavioral healthcare software provides clinical functions such as scheduling appointments, claim filings, documentation, and billing that help to increase the productivity of healthcare facilities
Key players are adopting strategies such as mergers and acquisitions to strengthen their market presence. In February 2021, Cerner Corporation announced integrating the virtual mental health platform of SilverCloud Health with its Electronic Health Records (EHR) solution. This integration will enable clinicians to prescribe various digitally delivered, scientifically-backed, and on-demand therapeutic care for behavioral health needs